Login / Signup

Clindamycin Mono-Therapy of Hidradenitis Suppurativa Patients: A Single-Center Retrospective Study.

Ji Hae AnSu Jin MoonJung U ShinDong Hyun KimMoon Soo YoonHee Jung Lee
Published in: Annals of dermatology (2021)
Systemic CL mono-therapy may be a safe and useful alternative to RF-CL combination therapy, and no significant difference in the efficacy of the therapy depending on the presence of CL-resistant bacteria was observed.
Keyphrases
  • combination therapy
  • end stage renal disease
  • hidradenitis suppurativa
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • stem cells
  • cell therapy
  • patient reported outcomes